HLA Typing for Transplant Segmentation
Technology (Molecular Assay Technologies, Serological Assays)
Based on technology, the molecular assay technology segment is expected to garner the highest share of 87.2% in the HLA typing for transplant market by the end of 2037. The dominance of the segment is attributable to their high procedural efficacy, reduced turnaround times, and their enhanced ability to analyze multiple samples at the same time. Moreover, these technologies offer high-resolution typing, which is highly essential for matching donors and recipients more accurately, reducing the risk of graft rejection. Besides the advantages offered by them make them a preferred choice for HLA typing in transplant diagnostics, thereby accelerating the segment’s dominance.
Application (Diagnostic, Research)
Based on application, the diagnostics segment is projected to account for a lucrative share of 70.3% in the HLA typing for transplant market during the forecast period. The segment benefits from increasing demand for accurate and timely interventions in HLA typing transplant procedures. Besides the ongoing advancements in molecular assays and the increasing instances of transplant surgeries across all nations, this drives business in the field, further contributing to the segment’s growth.
Our in-depth analysis of the HLA typing for transplant market includes the following segments:
|
Technology |
|
|
Application |
|
|
End User |
|
